Heartflow, Inc. HTFL
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus
Chart by TradingView
4/9
Piotroski F — financial health
-2.45
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $176.0M | -$116.8M | $135.2M | -$59.0M | $300.6M |
| 2024 | $125.8M | -$96.4M | $94.4M | -$73.4M | -$859.5M |
Why these scores methodology →
Piotroski F-score: 4/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -2.45 (distress)
- Working capital / assets 0.495
- Retained earnings / assets -3.026
- EBIT / assets -0.178
- Equity / liabilities 5.113
Source: SEC EDGAR filings · CIK 0001464521 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.